ReviewMedical oncology (Northwood, London, England)2021

Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review.

Priyanka Singh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.